Jucker: Progress in Drug Research/Fortschritte der Arzneimit

Softcover Nachdruck of the original 1. Auflage 1987
ISBN: 978-3-0348-9981-9
Verlag: Springer

Buch, Englisch, Band 31, 526 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 807 g

Reihe: Progress in Drug Research

Volume 31 of "Progress in Drug Research" contains 13 articles, a sub­ ject index, an index for all articles that have been published so far in this series of monographs, as well as an author and subject index for all 31 volumes. The reviews in this volume are particularly concerned with the therapy of helminth diseases, with pyramidinones as biody­ namic agents, and with quinolones which are of interest in the treat­ ment of infections. For a deeper understanding of the pharmacokinet­ ic actions of modem drugs, the articles on cooperative binding of drug molecules to DNA, on in vitro models for the study of antibiotic activi­ ties, on inhibitors of the renin-angiotensin system, on GAB A-drug in­ teractions, and on the mechanism of action of anxiolytic drugs provide a wealth offacts and new findings. The pharmacology of caffeine is re­ viewed from the viewpoint of its role in combination with other phy­ siologically active substances, and the chapter on high resolution nuc­ lear magnetic resonance spectroscopy demonstrates the importance of this method in the development of new drugs. Finally, the article on light and dark touches border problems of the therapy of psychic dis­ orders. With these contributions, the authors aim to summarize latest achieve­ ments in important and actual fields of drug research. Researchers who are actively engaged in the same or in similar fields of research are sure to benefit from these efforts.

Zielgruppe

Research

Autoren/Hrsg.

JUCKER

Inhaltsverzeichnis

· Inhalt · Sommaire.- Treatment of helminth diseases — challenges and achievements.- Ribonucleotide reductase inhibitors as anticancer and antiviral agents.- Pyrimidinones as biodynamic agents.- Enzyme inhibitors of the renin-angiotensin system.- Cooperative effects in drug-DNA interactions.- GABA-drug interactions.- Quinolones.- Risk assessment problems in chemical oncogenesis.- The pharmacology of caffeine.- Mechanism of action of anxiolytic drugs.- In vitro models for the study of antibiotic activities.- Light and dark as a “drug”.- High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development.- Index · Sachverzeichnis · Table des matières, Vol. 31.- Index of titles · Verzeichnis der Titel · Index des titres, Vol. 1–31.- Author and paper index · Autoren- und Artikelindex · Index des auteurs et des articles, Vol. 1–31.